|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rohatgi PR, Yao JC, Hess K, Schnirer I,
Rashid A, Mansfield PF, Pisters PW and Ajani JA: Outcome of gastric
cancer patients after successful gastrectomy: Influence of the type
of recurrence and histology on survival. Cancer. 107:2576–2580.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vogelstein B and Kinzler KW: The multistep
nature of cancer. Trends Genet. 9:138–141. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao Y, Zhou T, Li A, Yao H, He F, Wang L
and Si J: A potential role of collagens expression in
distinguishing between premalignant and malignant lesions in
stomach. Anat Rec (Hoboken). 292:692–700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshioka H, Greenwel P, Inoguchi K, Truter
S, Inagaki Y, Ninomiya Y and Ramirez F: Structural and functional
analysis of the promoter of the human alpha 1(XI) collagen gene. J
Biol Chem. 270:418–424. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Richards AJ, Yates JR, Williams R, Payne
SJ, Pope FM, Scott JD and Snead MP: A family with Stickler syndrome
type 2 has a mutation in the COL11A1 gene resulting in the
substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum
Mol Genet. 5:1339–1343. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khalifa O, Imtiaz F, Allam R, Al-Hassnan
Z, Al-Hemidan A, Al-Mane K, Abuharb G, Balobaid A, Sakati N, Hyland
J, et al: A recessive form of Marshall syndrome is caused by a
mutation in the COL11A1 gene. J Med Genet. 49:246–248. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Griffith AJ, Sprunger LK, Sirko-Osadsa DA,
Tiller GE, Meisler MH and Warman ML: Marshall syndrome associated
with a splicing defect at the COL11A1 locus. Am J Hum Genet.
62:816–823. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mio F, Chiba K, Hirose Y, Kawaguchi Y,
Mikami Y, Oya T, Mori M, Kamata M, Matsumoto M, Ozaki K, et al: A
functional polymorphism in COL11A1, which encodes the alpha 1 chain
of type XI collagen, is associated with susceptibility to lumbar
disc herniation. Am J Hum Genet. 81:1271–1277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fischer H, Stenling R, Rubio C and
Lindblom A: Colorectal carcinogenesis is associated with stromal
expression of COL11A1 and COL5A2. Carcinogenesis. 22:875–878. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Badea L, Herlea V, Dima SO, Dumitrascu T
and Popescu I: Combined gene expression analysis of whole-tissue
and microdissected pancreatic ductal adenocarcinoma identifies
genes specifically overexpressed in tumor epithelia.
Hepatogastroenterology. 55:2016–2027. 2008.PubMed/NCBI
|
|
12
|
Chong IW, Chang MY, Chang HC, Yu YP, Sheu
CC, Tsai JR, Hung JY, Chou SH, Tsai MS, Hwang JJ, et al: Great
potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1
markers for diagnosis of patients with non-small cell lung cancer.
Oncol Rep. 16:981–988. 2006.PubMed/NCBI
|
|
13
|
Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao
C, Ning L, Fang Z, Wang Y, Zhang L, et al: Differentially expressed
genes between primary cancer and paired lymph node metastases
predict clinical outcome of node-positive breast cancer patients.
Breast Cancer Res Treat. 103:319–329. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sok JC, Lee JA, Dasari S, Joyce S,
Contrucci SC, Egloff AM, Trevelline BK, Joshi R, Kumari N, Grandis
JR, et al: Collagen type XI α1 facilitates head and neck squamous
cell cancer growth and invasion. Br J Cancer. 109:3049–3056. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu YH, Chang TH, Huang YF, Huang HD and
Chou CY: COL11A1 promotes tumor progression and predicts poor
clinical outcome in ovarian cancer. Oncogene. 33:3432–3440. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
García-Pravia C, Galván JA,
Gutiérrez-Corral N, Solar-García L, García-Pérez E, García-Ocaña M,
Del Amo-Iribarren J, Menéndez-Rodríguez P, García-García J, de Los
Toyos JR, et al: Overexpression of COL11A1 by cancer-associated
fibroblasts: Clinical relevance of a stromal marker in pancreatic
cancer. PLoS One. 8:e783272013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vecchi M, Nuciforo P, Romagnoli S,
Confalonieri S, Pellegrini C, Serio G, Quarto M, Capra M, Roviaro
GC, Avesani E Contessini, et al: Gene expression analysis of early
and advanced gastric cancers. Oncogene. 26:4284–4294. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hunter T and Pines J: Cyclins and cancer.
II: Cyclin D and CDK inhibitors come of age. Cell. 79:573–582.
1994.
|
|
19
|
Kozar K and Sicinski P: Cell cycle
progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell
Cycle. 4:388–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoon MK, Mitrea DM, Ou L and Kriwacki RW:
Cell cycle regulation by the intrinsically disordered proteins p21
and p27. Biochem Soc Trans. 40:981–988. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salvesen GS: Caspases: Opening the boxes
and interpreting the arrows. Cell Death Differ. 9:3–5. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ghavami S, Hashemi M, Ande SR, Yeganeh B,
Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, et
al: Apoptosis and cancer: Mutations within caspase genes. J Med
Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tong QS, Zheng LD, Wang L, Zeng FQ, Chen
FM, Dong JH and Lu GC: Downregulation of XIAP expression induces
apoptosis and enhances chemotherapeutic sensitivity in human
gastric cancer cells. Cancer Gene Ther. 12:509–514. 2005.PubMed/NCBI
|
|
24
|
Wiedemeyer WR, Dunn IF, Quayle SN, Zhang
J, Chheda MG, Dunn GP, Zhuang L, Rosenbluh J, Chen S, Xiao Y, et
al: Pattern of retinoblastoma pathway inactivation dictates
response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci USA.
107:11501–11506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lyu JH, Park DW, Huang B, Kang SH, Lee SJ,
Lee C, Bae YS, Lee JG and Baek SH: RGS2 suppresses breast cancer
cell growth via a MCPIP1-dependent pathway. J Cell Biochem.
116:260–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wolff DW, Xie Y, Deng C, Gatalica Z, Yang
M, Wang B, Wang J, Lin MF, Abel PW and Tu Y: Epigenetic repression
of regulator of G-protein signaling 2 promotes androgen-independent
prostate cancer cell growth. Int J Cancer. 130:1521–1531. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Subramanian N, Navaneethakrishnan S,
Biswas J, Kanwar RK, Kanwar JR and Krishnakumar S: RNAi mediated
Tiam1 gene knockdown inhibits invasion of retinoblastoma. PLoS One.
8:e704222013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu JM and Yu PW: Downregulation of T-cell
lymphoma invasion and metastasis-inducing factor 1 induces
cytoskeletal rearrangement and inhibits the invasive capacity of
gastric cancer cells. Mol Med Rep. 8:425–433. 2013.PubMed/NCBI
|
|
29
|
Huang Z, Zhuo Y, Shen Z, Wang Y, Wang L,
Li H, Chen J and Chen W: The role of NEFL in cell growth and
invasion in head and neck squamous cell carcinoma cell lines. J
Oral Pathol Med. 43:191–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Capasso M, Diskin S, Cimmino F, Acierno G,
Totaro F, Petrosino G, Pezone L, Diamond M, McDaniel L, Hakonarson
H, et al: Common genetic variants in NEFL influence gene expression
and neuroblastoma risk. Cancer Res. 74:6913–6924. 2014. View Article : Google Scholar : PubMed/NCBI
|
